Research Programs
Petrie-Flom Center: Health Law, Biotech and Bioethics
-
From far and wide to master the law
March 20, 2024
Students from across the globe come to Harvard Law School to engage in graduate studies in law as part of Harvard Law School's LL.M. and S.J.D. programs.
-
Why it’s so hard to end homelessness in America
January 30, 2024
Experts cite the complexity of the problem of homelessness, which is rooted in poverty and lack of affordable housing, but includes medical, psychiatric and substance-use issues.
-
Why regulators may toss cold water on buzz over psychedelics
January 26, 2024
Psychedelic drugs show promise as a new treatment option for some psychiatric maladies, but experts see a possible state and federal legal clash.
-
Inquiring Mind
June 27, 2023
I. Glenn Cohen ’03 has always been fascinated with how things and people work, and with parsing thorny ethical dilemmas. He loves science and the law, and he’s been blending those passions for years as a legal scholar focused on bioethics.
-
Harvard Law School’s Carmel Shachar examines a lawsuit by pharmaceutical giant Merck contesting a provision of the Inflation Reduction Act.
-
Susannah Baruch, an expert in health law policy and ethics, joins Petrie-Flom Center as executive director
June 20, 2023
Susannah Baruch has joined the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School as executive director.
-
New faculty appointments
April 18, 2023
Harvard Law School expands the ranks of its faculty with four appointments.
-
Carmel Shachar named assistant clinical professor of law
April 14, 2023
Carmel Shachar J.D./M.P.H. ’10 has been appointed assistant clinical professor and faculty director of the Health Law and Policy Clinic at Harvard Law School.
-
Lessons of Roe, 50 years later
February 2, 2023
Speakers at a Radcliffe Institute conference look at the divisive, fraught history of Roe v. Wade and predict where legal battles will go next.
-
Could a California lawsuit lower the cost of insulin in the US?
January 25, 2023
Harvard Law expert Carmel Shachar says if California wins its suit against drug manufacturers, it could make the lifesaving drug more affordable for everyone.
-
Why did so many buy COVID misinformation? It works like magic.
January 20, 2023
Harvard Law panelists say both exploit how brains process information.
-
‘He showed me what it meant to lead with love’
December 14, 2022
Harvard Law Clinical Professor Robert Greenwald retires after a long career securing health care access for vulnerable populations.
-
On the bookshelf
December 13, 2022
This fall, Harvard Law School showcased the works of faculty, alums, and students at book events throughout the semester.
-
Lesson from Latin America for US abortion rights movement
October 28, 2022
This article was originally published in the Harvard Gazette. Mexico and Colombia recently legalized abortion in landmark rulings that offer a stark contrast to…
-
The Petrie-Flom Center hosted ‘Roe in limbo: A town hall on the leaked Dobbs opinion.’
-
Reassessing Psychedelics
January 31, 2022
A new Harvard Law initiative examines the legal and ethical aspects of therapeutic psychedelics
-
Glenn Cohen and Carmel Shachar reflect on the administration’s successes, failures, and agenda for the future.
-
The obstacles to decriminalizing psychedelic drugs are political, not legal, say experts
October 13, 2021
The new Project on Psychedelics Law and Regulation (POPLAR) at Harvard Law School recently convened a conference on the future of psychedelics law and regulation.